Syros Pharmaceuticals, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 09/16/2022   Download
SEC Document
SEC Filing

The Company convened and adjourned its special meeting of stockholders on September 15, 2022 (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved an amendment to the restated certificate of incorporation of the Company (the “Share Increase Amendment”) to effect a share increase of the number of authorized shares of the Company’s common stock from 200,000,000 shares to 700,000,000 shares (on a pre-split basis) (the “Share Increase”). On September 15, 2022, the Company filed the Share Increase Amendment with the Secretary of State of the State of Delaware to effect the Share Increase effective on September 15, 2022. As a result of the Share Increase, the number of issued and outstanding shares of the Company’s common stock was increased from 200,000,000 shares to 700,000,000 shares.